Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer

Cancer Genomics and Proteomics

Volumn 7, Issue 5, 2010, Pages 245-252

  Liss, Michael A ^a   Schlicht, Michael ^b   Kahler, Andrea ^c   Fitzgerald, Ryan ^d   Thomassi, Taylor ^e   Degueme, Amy ^c   Hessner, Martin ^c   Datta, Milton W ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d HARVARD UNIVERSITY   (United States)

^e GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Beta catenin; Frizzled; Gene expression; Genistein; Prostate cancer; Soy protein

Indexed keywords

BETA CATENIN; BROXURIDINE; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3; SMALL INTERFERING RNA; SOYBEAN PROTEIN; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL LABELING; ENZYME ACTIVATION; GROWTH CURVE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOYBEAN; WESTERN BLOTTING;

RATTUS;

EID: 78149235882     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG and Edwards BK (eds.): SEER Cancer Statistics Review, 1975-2006, Bethesda, MD: National Cancer Institute.
2. Severson RK, Nomura AM, Grove JS, Stemmermann GN: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49: 1857-1860, 1989,
3. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM and West DW: Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87(9): 652-661, 1995.
4. Adlercreutz H: Phytoestrogens: Epidemiology and a possible role in cancer protection. Environ Health Perspect 103: 103-112, 1995.
5. Pollard M and Wolter W: Prevention of spontaneous prostate related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet. Prostate 45: 101-105, 2000.
6. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC and Bergan RC: Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 68: 2024-2032, 2008.
7. Wang J, Eltoum IE and Lamartiniere CA: Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats. Cancer Lett 186: 11-18, 2002.
8. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM and Elgavish A: Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 61(18): 6777-6782, 2001.
9. El Touny LH and Banerjee PP: Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. Carcinogenesis 28(8): 1710-1717, 2007.
10. Bierie B, Nozawa M, Renou JP, Shillingford JM, Morgan F, Oka T, Taketo MM, Cardiff RD, Miyoshi K, Wagner KU, Robinson GW and Hennighausen L: Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Oncogene 22: 3875-3887, 2003.
11. Chesire DR, Ewing CM, Gage WR and Isaacs WB: In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis. Oncogene 21: 2679-2694, 2002.
12. Gounari F, Signoretti S, Bronson R, Klein L, Sellers WR, Kum J, Siermann A, Taketo MM, von Boehmer H and Khazaie K: Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia. Oncogene 21(26): 4099-4107, 2002.
13. Robinson D, Zylstra C and Williams B: Wnt signaling and prostate cancer. Current Drug Targets 9(7): 571-580, 2008
14. Yardy GW and Brewster SF: Wnt signalling and prostate cancer. Prostate Cancer Prostatic Dis 8(2): 119-126, 2005.
15. Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D and Rabbani SA: Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 101: 1345-1356, 2004.
16. Lu W, Tinsley HN, Keeton A, Qu Z, Piazza GA and Li Y: Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. Eur J Pharmacol 602(1): 8-14, 2009
17. Gerstein AV, Almeida TA, Zhao G, Chess E, Shih IeM, Buhler K, Pienta K, Rubin MA, Vessella R and Papadopoulos N: APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer 34(1): 9-16, 2002.
18. Voeller HJ, Truica CI and Gelmann EP: Beta-catenin mutations in human prostate cancer. Cancer Res 58(12): 2520-2523, 1998.
19. Liss MA, Schlicht M, Degume A, Hessner M and Datta MW: Use of cross species genomic profiling identifies pathways and genes differentially regulated in prostate cancer cells treated with soy protein isolates or purified genistein. Cancer Genomics Proteomics 7(3): 2010
20. Pollard M, Wolter W and Sun L: Prevention of induced prostate-related cancer by soy protein isolate/isoflavone-supplemented diet in Lobund-Wistar rats. In Vivo 14(3): 389-392, 2000.
21. Pollard M and Luckert PH: Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr Cancer 28(1): 41-45, 1997.
22. Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W and Kikuchi A: Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 29(14): 2036-2046, 2010.